BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 852545)

  • 21. [The effect of atenolol on contractility and hemodynamics of the infarcted heart in comparison to propranolol and practolol (author's transl)].
    Stephan K; Meesmann W; Bischoff KO; Hübner H; Geigenmüller L; Diesch J
    Arzneimittelforschung; 1975 Nov; 25(11):1770-6. PubMed ID: 1243085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hemodynamic effects of S-nitrosocysteine, an intravenous regional vasodilator.
    Stuesse DC; Giraud GD; Vlessis AA; Starr A; Trunkey DD
    J Thorac Cardiovasc Surg; 2001 Aug; 122(2):371-7. PubMed ID: 11479512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The effect of prazosin on the hemodynamics of the anesthetized dog].
    Komarek J
    Arzneimittelforschung; 1978; 28(12):2228-32. PubMed ID: 582935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The effect of reserpine, guanethidine and methyldopa on general and regional hemodynamics].
    Iuzhakov SD; Kotliarov EV
    Farmakol Toksikol; 1973; 26(4):429-32. PubMed ID: 4789888
    [No Abstract]   [Full Text] [Related]  

  • 25. Characteristic cardiovascular effects of RA642, a pyrimido-pyrimidine derivative, in anesthetized dogs.
    Koyama S
    J Pharmacol Exp Ther; 1985 May; 233(2):480-4. PubMed ID: 3999030
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Influence of modern inhalation anaesthetics on haemodynamics, myocardial contractility, left ventricular volumes and myocardial oxygen supply (author's transl)].
    Tarnow J; Eberlein HJ; Oser G; Patschke D; Schneider E; Schweichel E; Wilde J
    Anaesthesist; 1977 May; 26(5):220-30. PubMed ID: 879490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cardiovascular effects of glucagon].
    Lavarenne J
    Therapie; 1974; 29(2):161-84. PubMed ID: 4368071
    [No Abstract]   [Full Text] [Related]  

  • 28. Hemodynamic effects of vasopressin during haemorrhagic hypotension in the anesthetized dog.
    Ericsson BF
    Acta Chir Scand; 1972; 138(3):227-33. PubMed ID: 5036819
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effect of atenolol and propranolol on systemic and regional hemodynamics].
    Medvedev OS; Iuzhakov SD; Mashkovskiĭ MD; Val'dman AV; Ismailov ShI
    Biull Eksp Biol Med; 1983 Jul; 96(7):59-61. PubMed ID: 6871455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systemic and regional hemodynamic effects of isomazole in awake dogs with congestive heart failure.
    Imai N; Liang CS; Stone CK; Hayes JS; Hood WB
    J Pharmacol Exp Ther; 1987 Apr; 241(1):20-6. PubMed ID: 3572783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hemodynamic effects of cadralazine in hexamethonium treated and non-treated anesthetized dogs.
    Higashio T; Tsuji Y; Nakao K; Sakaguchi S; Tanaka M
    Arzneimittelforschung; 1988 Mar; 38(3):350-8. PubMed ID: 3382459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of the cardiovascular, renal, and coronary effects of dopamine and monensin in endotoxic shock.
    Somani P; Saini RK
    Circ Shock; 1981; 8(4):451-64. PubMed ID: 7023738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of magnesium chloride on cardiovascular hemodynamics in the neurally intact dog.
    Friedman HS; Nguyen TN; Mokraoui AM; Barbour RL; Murakawa T; Altura BM
    J Pharmacol Exp Ther; 1987 Oct; 243(1):126-30. PubMed ID: 3668845
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological investigation of cardiovascular and haemodynamic effects of salts of ioxitalamic acid in anaesthetized dogs.
    Cheymol G; Mouillé P; Grasland D
    Arzneimittelforschung; 1977 Feb; 27(2):393-7. PubMed ID: 577160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Change in systemic hemodynamics under the influence of vasopressin in dogs during ontogenesis].
    Brin VB
    Biull Eksp Biol Med; 1977 Mar; 83(3):261-3. PubMed ID: 851627
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of amantadine on heart and circulation].
    van Ackern K; Deuster JE; Mast GJ; Schmier J
    Arzneimittelforschung; 1975 Jun; 25(6):891-6. PubMed ID: 51642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cardiovascular effect of 15(S)-15-methyl-prostaglandin F2alpha].
    Retzke U; Schwarz R
    Zentralbl Gynakol; 1978; 100(8):504-9. PubMed ID: 664974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiopulmonary actions of prostaglandin 6-keto-E1 in the anesthetized dog.
    Nandiwada P; Hyman AL; Feigen LP; Kadowitz PJ
    Arch Int Pharmacodyn Ther; 1980 May; 245(1):118-28. PubMed ID: 7190813
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological studies on 3-[gamma-(p-fluorobenzoyl)propyl]-2,3,4,4a,5,6-hexahydro-1 (H)-pyrazino(1,2-a) quinoline hydrochloride (compound 69/183). Part II: Effect on cardiac dynamics.
    Srimal RC; Mason DF; Dhawan BN
    Arzneimittelforschung; 1978; 28(7):1092-5. PubMed ID: 582695
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological studies of OPC-2009, a newly synthesized selective beta adrenoceptor stimulant, in the broncho-motor and cardiovascular system of the anesthetized dog.
    Yabuuchi Y; Yamashita S; Tei SS
    J Pharmacol Exp Ther; 1977 Aug; 202(2):326-36. PubMed ID: 18598
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.